Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells
- 31 January 2009
- journal article
- research article
- Published by Elsevier BV in Human Immunology
- Vol. 70 (1), 16-23
- https://doi.org/10.1016/j.humimm.2008.10.016
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsBlood, 2005
- Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsivenessBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Nonexpanded primary lung and bone marrow–derived mesenchymal cells promote the engraftment of umbilical cord blood–derived CD34+ cells in NOD/SCID miceExperimental Hematology, 2003
- Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsTransplantation, 2003
- Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantationBlood, 2003
- Immunomodulatory effects of human foetal liver-derived mesenchymal stem cellsBone Marrow Transplantation, 2003
- Biotinylated DRB sequence-specific oligonucleotides Comparison to serologic HLA-DR typing of organ donors in eurotransplantHuman Immunology, 1993
- Comparison of the Proportions of Leukocytes in Early and Term Human DeciduaAmerican Journal of Reproductive Immunology, 1993
- Immunologic privilege in the eye and the fetusImmunology Today, 1987